Avant BrandsAVTBF +0.45%29 Market Cap is $6.17 Mil as of Jul. 03, 2026. GuruFocus rates AVTBF with a GF Score™ of 29/100 and a GF Value™ of $0.93 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Avant Brands ranks worse than 88.57% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avant Brands's share price for the quarter that ended in Feb. 2026 was $0.6289. Avant Brands's Shares Outstanding (EOP) for the quarter that ended in Feb. 2026 was 11.41 Mil. Therefore, Avant Brands's market cap for the quarter that ended in Feb. 2026 was $7.17 Mil.
Avant Brands's quarterly market cap
declined
from Aug. 2025 ($7.63 Mil) to Nov. 2025 ($6.40 Mil) but then
increased
from Nov. 2025 ($6.40 Mil) to Feb. 2026 ($7.17 Mil).
Avant Brands's annual market cap
declined
from Nov. 2023 ($26.94 Mil) to Nov. 2024 ($4.14 Mil) but then
increased
from Nov. 2024 ($4.14 Mil) to Nov. 2025 ($6.40 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avant Brands's Enterprise Value for Today is $15.99 Mil.
Avant Brands (OTCPK:AVTBF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avant Brands Market Cap Related Terms
Avant Brands Market Cap Historical Data
* Premium members only.
The historical data trend for Avant Brands's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avant Brands Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avant Brands's Market Cap distribution charts can be found below:
* The bar in red indicates where Avant Brands's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avant Brands's Market Cap for the fiscal year that ended in Nov. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avant Brands (AVTBF) has a Market Cap of $6.17 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avant Brands and its competitors. According to the industry distribution chart, Avant Brands ranks #907 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 88.6%.
Is Avant Brands' Market Cap too high?
Avant Brands' current Market Cap is $6.17 Mil. The Drug Manufacturers industry median Market Cap is 217.83. Avant Brands' value of $6.17 Mil is 97.2% below this industry median. Based on the distribution chart, Avant Brands ranks #907 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Avant Brands has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #907 out of 1024 companies for Market Cap. This places Avant Brands in the lower half of its industry. The industry median Market Cap is 217.83. Avant Brands' value of $6.17 Mil is 97.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 217.83, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avant Brands's current Market Cap of $6.17 Mil is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avant Brands and its competitors. For the Drug Manufacturers industry, the median Market Cap is 217.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avant Brands's current Market Cap is $6.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (AVTBF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.93, compared to a current price of $0.41 — trading 55.7% below its estimated fair value. The current Market Cap is $6.17 Mil and 97.2% below the Drug Manufacturers industry median of 217.83. Avant Brands' overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Avant Brands (AVTBF), the current Market Cap is $6.17 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avant Brands (AVTBF) Overvalued in 2026?
Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued.
The current stock price of $0.41 is trading 55.7% below its estimated GF Value™ of $0.93.
GuruFocus considers Avant Brands to be Possible Value Trap.
Key valuation signals for AVTBF:
Market Cap: $6.17 Mil
GF Value™: $0.93 vs. price of $0.41 (55.7% below fair value)
Industry Position: 97.2% below the Drug Manufacturers median (#907 of 1024)
No single metric tells the full story. See the AVTBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
29GF Score
Get the complete analysis for AVTBF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVTBF has been successfully added to your 
